Pyrazolotriazines as inhibitors of nucleases
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14310%2F18%3A00103059" target="_blank" >RIV/00216224:14310/18:00103059 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1021/JO00162A007" target="_blank" >http://dx.doi.org/10.1021/JO00162A007</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1021/JO00162A007" target="_blank" >10.1021/JO00162A007</a>
Alternative languages
Result language
angličtina
Original language name
Pyrazolotriazines as inhibitors of nucleases
Original language description
The present invention relates to substituted heterocycles as inhibitors of nudeases MUS81 and MRE11, pharmaceutical compositions containing the compounds, and pharmaceutical use of the compounds and compositions in the treatment of the diseases such as, for example, cancer.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
<a href="/en/project/LM2015063" target="_blank" >LM2015063: National Infrastructure for Chemical Biology</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
JP 6313906
Publisher
JP001 -
Publisher name
Japan Patent Office (JPO)
Place of publication
Tokyo
Publication country
JP - JAPAN
Date of acceptance
Mar 30, 2018
Owner name
Masarykova univerzita
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence